• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种茶碱缓释制剂治疗慢性阻塞性肺疾病

Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.

作者信息

Giosue S, Bernocchi D, Parola D, Munno R, Mancini P

机构信息

Second Pneumological Department, La Sapienza Hospital, University of Rome, Italy.

出版信息

J Int Med Res. 1987 Nov-Dec;15(6):352-60. doi: 10.1177/030006058701500604.

DOI:10.1177/030006058701500604
PMID:3325318
Abstract

A sustained-release theophylline preparation in capsule form was compared with standard slow-release theophylline tablets for variation in plasma theophylline concentration, effectiveness and tolerability in 30 adults with chronic broncho-obstructive pathology. They were administered every 12 h and blood samples were collected after 8 days of treatment during the steady-state period. In this double-dummy crossover study, the sequence of the two regimens (sustained-release capsules versus tablets) was selected at random. The results of this study demonstrate that plasma theophylline levels remain within the therapeutic range for both preparations. Effectiveness and tolerability of the two drugs were satisfactory.

摘要

在30名患有慢性支气管阻塞性病变的成年人中,对胶囊形式的缓释茶碱制剂与标准缓释茶碱片进行了比较,观察其血浆茶碱浓度变化、有效性和耐受性。两种制剂均每12小时给药一次,并在稳态期治疗8天后采集血样。在这项双盲交叉研究中,随机选择两种治疗方案(缓释胶囊与片剂)的给药顺序。该研究结果表明,两种制剂的血浆茶碱水平均保持在治疗范围内。两种药物的有效性和耐受性均令人满意。

相似文献

1
Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.两种茶碱缓释制剂治疗慢性阻塞性肺疾病
J Int Med Res. 1987 Nov-Dec;15(6):352-60. doi: 10.1177/030006058701500604.
2
A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
Int J Clin Pharmacol Res. 1987;7(5):345-50.
3
Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者中标准释放型和缓释型茶碱片的比较。
Am J Hosp Pharm. 1979 May;36(5):613-7.
4
Clinical experience with two twice daily slow release theophylline preparations. Relation between serum theophylline concentrations, effectiveness, tolerability and compliance in elderly patients.两种每日两次缓释茶碱制剂的临床经验。老年患者血清茶碱浓度、有效性、耐受性与依从性之间的关系。
J Int Med Res. 1987 May-Jun;15(3):170-8. doi: 10.1177/030006058701500308.
5
Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
Int J Clin Pharmacol Ther Toxicol. 1985 Oct;23(10):560-4.
6
Long-term therapy with sustained-release theophylline.
Pharmatherapeutica. 1985;4(2):92-7.
7
Controlled release salbutamol tablets versus sustained release theophylline tablets in the control of reversible obstructive airways disease.控释沙丁胺醇片与缓释茶碱片对可逆性阻塞性气道疾病的控制作用比较
J Int Med Res. 1989 Jan-Feb;17(1):93-8. doi: 10.1177/030006058901700114.
8
A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.一项针对重度慢性阻塞性肺疾病患者的茶碱随机对照试验。
N Engl J Med. 1989 Jun 8;320(23):1521-5. doi: 10.1056/NEJM198906083202304.
9
Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.与每日两次服用茶硷控释片相比,每日一次服用优喘平片在老年慢性气流阻塞患者中的安全性和有效性。
Am J Med. 1988 Jul 29;85(1B):48-53. doi: 10.1016/0002-9343(88)90242-2.
10
Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
Clin Ther. 1986;8(2):175-80.